期刊文献+

p16基因突变与子宫内膜癌关系的研究 被引量:2

Study on the relationship between the mutations of p16 gene and endometrial carcinoma
下载PDF
导出
摘要 目的 研究 p16基因的突变在子宫内膜癌发生、发展中的作用。 方法 应用PCR SSCP及DNA测序对 4 0例子宫内膜癌中 p16基因第二外显子缺失及序列改变进行研究。 结果  4 0例子宫内膜癌中 12例存在 p16基因的第二外显子 5 2 2bp的纯合缺失 ,10例存在点突变 (突变位点相同 ) ,突变位点之一为第 12 6密码子硷基GTC→AAT(错义突变 ) ,另一突变位点为第 12 7密码子GCA→GCG(同义突变 ) ,缺失及突变共占 5 5 %。结论 p16基因的突变与子宫内膜癌的发生有明显的相关性。 Objective To study the relationship between the alterations of p16 gene and the occurrence and development of the endometrial carcinoma.Methods The alterations of p16 gene were studied by ploymerase chain reaction single strand conformation polymorphism(PCR SSCP) and DNA sequencing in 40 endometrial carcinomas. Results The exon 2 of p16 gene occurred 522bp homozygous deletion in 12 cases. The point mutations at the same site were detected in 10 cases, and one of mutating sites was GTC→AAT(Val126Asn) on 126th codon, another mutating site was GCA →GCG(A127A) on 127th codon. The ratio of alterations of p16 gene was 55%.Conclusion The alterations of p16 gene correlate with the occurrence of endometrial carcinoma.
出处 《肿瘤防治研究》 CAS CSCD 2003年第1期23-25,共3页 Cancer Research on Prevention and Treatment
关键词 P16基因 基因突变 子宫内膜癌 p16 gene Mutation Endometrial carcinoma
  • 相关文献

参考文献1

共引文献2

同被引文献17

  • 1李志琴,章静波.细胞周期调控与肿瘤(1)[J].癌症进展,2004,2(1):70-75. 被引量:20
  • 2王鹤,陈心秋,李菲.45岁以下子宫内膜癌41例临床分析[J].肿瘤学杂志,2006,12(5):418-419. 被引量:9
  • 3Kamb A, Gruis NA. Weaver Feldhaus J. et al. A cell cyxle regulator potentially involved In genesis of many tumor types. Science,2004, 264(5157) :436-439.
  • 4Kitawaki J, Kusuki I, Koshiba H, et al. Detection of aromatase cytochrome P-450 as a diagnostic test for en-dometriosis. Fertil Steril, 1999,72 : 1100-1106.
  • 5Serrano M, Hannon GJ, Beach D, ct al. A new regu latory motifin cell cycle control Causing specific inhibi tion of cyclinD/CDK4. Nature. 2004, 366 ( 16 ) : 704- 707.
  • 6Reed JA, Loganzo F,Shea CR, ct al. Loss of expression of the p16/cyclin-dependent kinase inhibitor of tnmor suppressor gene inmelanoeytic lesionscorrelates with invasive stage of tumor progression[J]. Cancer Res,2003, 55(13) :2713-2718.
  • 7Kanuma T, Nishida J, Cima T, et al. Alterations of the P16 INK4A gene in human ovarian cancers. Mol Carcinog,2003,18(3): 134-141.
  • 8Reed AL, Califano J,Caims P, et al. High frequency of P16 CDKN4/MYS. 1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res, 2004, 56 (16): 3630-3633.
  • 9Srkalovic G. Wittliff JK Schally AV. Detection and partial characterization of receptor for Luteinizing hormonere leasing hormone and epidermal growth factor in human endometrial carcinoma [J].Cancer Res, 2002,50 : 1841-1846.
  • 10Srkalovic G, Wittliff JF, Schally AV. Detection and partial characterization of receptor for [D-Trp6] -Luteinizing hormone releasing hormone and epidermal growth factor in human endometrial carcinoma [J]. Cancer Res, 1990, 50: 1841-1846.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部